Tocilizumab as a Treatment for ‘Cytokine Storm Syndrome’ in COVID-19: A Case Report

Tocilizumab as a Treatment for ‘Cytokine Storm Syndrome’ in COVID-19: A Case Report

Coronavirus disease 19 (COVID-19) which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been a problem worldwide, particularly due to the high rate of transmission and wide range of clinical manifestations. Acute respiratory distress syndrome (ARDS) and multiorgan fail...

Full description

Bibliographic Details
Main Authors: Ari Fahrial Syam, Ceva W Pitoyo, Suhendro Suhendro, Benny Zulkarnain, Nuri D Indrasari, Dita Aditianingsih, Cosphiadi Irawan, Adityo Susilo, Cleopas M Rumende, Ika P Wijaya, Fera Ibrahim, Menaldi Rasmin, Idrus Alwi, Dadang Makmun
Format: Article
Language:English
Published: Interna Publishing 2021-07-01
Series:Acta Medica Indonesiana
Subjects:
covid-19
sars-cov-2
acute respiratory distress syndrome (ards)
tocilizumab
Online Access:https://www.actamedindones.org/index.php/ijim/article/view/1825

Similar Items

Similar Items